RISSOMÉLASTINA Trademark

Trademark Overview

On Friday, January 8, 2016, a trademark application was filed for RISSOMÉLASTINA with the United States Patent and Trademark Office. The USPTO has given the RISSOMÉLASTINA trademark a serial number of 79183135. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, August 25, 2023. This trademark is owned by BCWORLD PHARM. CO., LTD.. The RISSOMÉLASTINA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of central nervous system (CNS) diseases
rissomÉlastina

General Information

Serial Number79183135
Word MarkRISSOMÉLASTINA
Filing DateFriday, January 8, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, August 25, 2023
Registration Number5139444
Registration DateTuesday, February 14, 2017
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, November 29, 2016

Trademark Statements

Description of MarkThe mark consists of the wording "RISSOMÉLASTINA" appearing in stylized form with a horizontal line appearing beneath "RISSOM" and "LASTINA".
Goods and ServicesPharmaceutical preparations for the treatment of central nervous system (CNS) diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBCWORLD PHARM. CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressKR
Party NameBCWORLD PHARM. CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressKR
Party NameBCWORLD PHARM. CO., LTD.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressKR

Trademark Events

Event DateEvent Description
Thursday, February 25, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, March 1, 2016APPLICATION FILING RECEIPT MAILED
Friday, April 29, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, April 29, 2016REFUSAL PROCESSED BY MPU
Friday, April 29, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, May 19, 2016REFUSAL PROCESSED BY IB
Tuesday, October 18, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 18, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 18, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 18, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, October 19, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 29, 2016PUBLISHED FOR OPPOSITION
Tuesday, November 29, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 14, 2017REGISTERED-PRINCIPAL REGISTER
Sunday, May 14, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, June 1, 2017FINAL DISPOSITION PROCESSED
Tuesday, April 26, 2016ASSIGNED TO EXAMINER
Thursday, April 28, 2016NON-FINAL ACTION WRITTEN
Tuesday, October 18, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, June 1, 2017FINAL DISPOSITION NOTICE SENT TO IB
Friday, June 16, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 26, 2021NEW REPRESENTATIVE AT IB RECEIVED
Monday, February 14, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, August 25, 2023CANCELLED SECTION 71
Thursday, April 25, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, May 6, 2024INVALIDATION PROCESSED
Monday, May 6, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, May 11, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, May 27, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Friday, December 10, 2021NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

lastina rissom system diseases nervous central preparations treatment pharmaceutical